8:15 AM ET
8-K
Leadership Change
Corcept Therapeutics Leadership Change
Sean Maduck, President of Corcept Endocrinology, is resigning effective October 1, 2026, and will be succeeded by Justin Gunn. Maduck will transition to a senior commercial advisor role under a consulting agreement paying $57,000 per month through September 2027.
- Counterparty
- Sean Maduck
- Term
- 1 year